Ernexa Therapeutics Inc. Warrants
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the tr… Read more
Ernexa Therapeutics Inc. Warrants (ERNAW) - Net Assets
Latest net assets as of : $- USD
Based on the latest financial reports, Ernexa Therapeutics Inc. Warrants (ERNAW) has net assets worth $- USD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Ernexa Therapeutics Inc. Warrants - Net Assets Trend (None–None)
This chart illustrates how Ernexa Therapeutics Inc. Warrants's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ernexa Therapeutics Inc. Warrants (None–None)
The table below shows the annual net assets of Ernexa Therapeutics Inc. Warrants from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Ernexa Therapeutics Inc. Warrants's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Ernexa Therapeutics Inc. Warrants Competitors by Market Cap
The table below lists competitors of Ernexa Therapeutics Inc. Warrants ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vulcan International Corporation
PINK:VULC
|
$455.50 |
|
DAPHNE INTL HLDGS
MU:PSX
|
$455.82 |
|
Goldenbridge Acquisition Limited
NASDAQ:GBRGW
|
$455.93 |
|
Thalassa Holdings Ltd
LSE:THAL
|
$455.97 |
|
Escorts Investment Bank Ltd
KAR:ESBL
|
$455.09 |
|
China Skyrise Digital Service Inc
OTCGREY:CSKD
|
$454.90 |
|
Ngernturbo Public Company Limited
BK:TURBO
|
$454.02 |
|
Neptune Wellness Solutions Inc
PINK:NEPTF
|
$453.00 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ernexa Therapeutics Inc. Warrants's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Ernexa Therapeutics Inc. Warrants's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Ernexa Therapeutics Inc. Warrants utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Ernexa Therapeutics Inc. Warrants's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ernexa Therapeutics Inc. Warrants (ERNAW) | $- | N/A | N/A | $455.10 |
| Abcam plc (ABCZF) | $726.90 Million | -1.17% | 0.45x | $5.00 Billion |
| Able View Global Inc. Warrant (ABLVW) | $11.42 Million | 85.41% | 3.81x | $277.93K |
| Above Food Ingredients Inc. Warrants (ABVEW) | $199.86 Million | -2.89% | 0.00x | $6.25 Million |
| Adamas Trust, Inc. (ADAMG) | $2.43 Billion | 7.94% | 1.33x | $2.09 Billion |
| ADS-TEC ENERGY PLC Warrant (ADSEW) | $33.92 Million | -162.39% | 2.67x | $10.06 Million |
| Alliance Entertainment Holding Corporation Warrants (AENTW) | $52.92 Million | 10.13% | 4.23x | $2.29 Million |
| Forafric Global PLC Warrants (AFRIW) | $5.32 Million | -457.58% | 45.29x | $2.67 Million |
| Centurion Acquisition Corp. Warrant (ALFUW) | $282.84 Million | 1.97% | 0.05x | $4.81 Million |
| Alliance Trust PLC (ALITF) | $4.04 Billion | 10.04% | 0.29x | $112.87K |
| Alvotech Warrant (ALVOW) | $-564.42 Million | 0.00% | 0.00x | $35.01 Million |